Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0577 Injection, brixadi, 7 days or less

J Codes (Drugs)

Also known as: brixadi, buprenorphine monthly, bup injection

Brixadi injection, 7 days or less duration, a long-acting buprenorphine formulation for subcutaneous administration in opioid use disorder treatment.

In Plain Language

short-acting buprenorphine injection; weekly opioid replacement shot

Clinical Context

Extended-release subcutaneous buprenorphine injection providing therapeutic levels for up to 7 days, improving adherence in opioid use disorder treatment. Administered weekly for initial induction phase.

RVU Information

CPT J0577 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

addiction medicineprimary carepsychiatry

Frequently Asked Questions

What is CPT code J0577?

CPT J0577 (Injection, brixadi, 7 days or less) is a J Codes (Drugs) code. Brixadi injection, 7 days or less duration, a long-acting buprenorphine formulation for subcutaneous administration in opioid use disorder treatment.

How is J0577 administered?

CPT J0577 is administered by a healthcare provider, typically via injection or infusion. Extended-release subcutaneous buprenorphine injection providing therapeutic levels for up to 7 days, improving adherence in opioid use disorder treatment. Administered weekly for initial induction phase. It is used by addiction medicine, primary care, psychiatry.

When is CPT J0577 used?

Extended-release subcutaneous buprenorphine injection providing therapeutic levels for up to 7 days, improving adherence in opioid use disorder treatment. Administered weekly for initial induction phase.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.